Ultravist
Product Images NDC 50419-342
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Ultravist (NDC 50419-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ndc 50419-348-20 (mexico) (F490274b 9be9 44e7 93c3 370cc2a7121a 01)
Ndc 50419-348-13 (F490274b 9be9 44e7 93c3 370cc2a7121a 02)
Ndc 50419-348-12 (africa) (F490274b 9be9 44e7 93c3 370cc2a7121a 03)
Ndc 50419-348-11 (F490274b 9be9 44e7 93c3 370cc2a7121a 04)
Ndc 50419-348-10 (F490274b 9be9 44e7 93c3 370cc2a7121a 05)
Ndc 50419-348-05 (middle East) (F490274b 9be9 44e7 93c3 370cc2a7121a 06)
Ndc 50419-347-20 (mexico) (F490274b 9be9 44e7 93c3 370cc2a7121a 07)
Ndc50419-347-05 (algeria) (F490274b 9be9 44e7 93c3 370cc2a7121a 08)
240mgi/50ml (Image 01)
300mgi/50ml (Image 02)
370mgi/50ml (Image 03)
This is a description of a medication in the form of a sterile solution for intra-vascular use only. The medication contains lopromide and Ultravist Tyetate. The stabilizer present is 370mgl/mL and does not contain any antimicrobial preservative. The medication should be protected from light, stored at a temperature range of 15-30°C, and any unused portion should be discarded. The recommended dosage is given in the package insert. The medication is produced by Bayer and is not to be used intrathecally.*
Structure (Vial Image 01)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.